Evidence map›Paper›PMID 33898595›Full record

ArticlemHealth2021

HIV self-testing and STI self-collection via mobile apps: experiences from two pilot randomized controlled trials of young men who have sex with men.

Katie B Biello, Casey Horvitz, Shelby Mullin, Kenneth H Mayer, Hyman Scott, Kenneth Coleman, Julian Dormitzer, Jenna Norelli, Lisa Hightow-Weidman, Patrick Sullivan and 6 more

Abstract read
In one paragraph

Article in mHealth, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. User Input in the Development of Digital Sexual Health Tools: A Scoping Review and Guidance for Tool Developers.Health expectations : an international journal of public participation in health care and health policy · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Katie B BielloDepartments of Behavioral & Social Health Sciences and Epidemiology, School of Public Health, Brown University, Providence, RI, USA.
Casey HorvitzInstitute for Global Health & Infectious Diseases, University of North Carolina, Chapel Hill, NC, USA.
Shelby MullinRollins School of Public Health, Emory University, Atlanta, GA, USA.
Kenneth H MayerThe Fenway Institute, Fenway Health, Boston, MA, USA.
Hyman ScottBridge HIV, San Francisco Department of Public Health, San Francisco, CA, USA.
Kenneth ColemanBridge HIV, San Francisco Department of Public Health, San Francisco, CA, USA.
Julian DormitzerThe Fenway Institute, Fenway Health, Boston, MA, USA.
Jenna NorelliRollins School of Public Health, Emory University, Atlanta, GA, USA.
Lisa Hightow-WeidmanInstitute for Global Health & Infectious Diseases, University of North Carolina, Chapel Hill, NC, USA.
Patrick SullivanRollins School of Public Health, Emory University, Atlanta, GA, USA.
Matthew J MimiagaDepartments of Behavioral & Social Health Sciences and Epidemiology, School of Public Health, Brown University, Providence, RI, USA.
Susan BuchbinderBridge HIV, San Francisco Department of Public Health, San Francisco, CA, USA.
Kelly BojanDivision of Adolescent Medicine, The Ruth M. Rothstein CORE Center, Chicago, IL, USA.
Donna FuttermanAdolescent AIDS Program, Children's Hospital at Montefiore, Bronx, NY, USA.
Patricia EmmanuelDepartment of Pediatrics, University of South Florida Morsani College of Medicine, Tampa, FL, USA.
Albert LiuBridge HIV, San Francisco Department of Public Health, San Francisco, CA, USA.

Funding

Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Ann M Chahroudi, Colleen F Kelley · 2002 to 2026
$74.0M
The UNC/Emory Center for Innovative Technology (iTech) across the prevention and care continuumU19HD089881 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HIGHTOW-WEIDMAN, LISA B, SULLIVAN, PATRICK SEAN · 2016 to 2022
$35.8M
Structural Factors and HIV and STI Incidence among Young MSM of Color in BostonU01HD068040 · NICHD · FENWAY COMMUNITY HEALTH CENTER · PI MAYER, KENNETH H · 2011 to 2015
$3.2M
NIAID NIH HHS P30 AI050409NICHD NIH HHS U01 HD068040NICHD NIH HHS U19 HD089881
6 · The paper itself

Abstract

backgroundYoung men who have sex with men (YMSM) are disproportionately impacted by HIV and other sexually transmitted infections (STIs) in the United States (US) and have low rates of HIV/STI testing. Provision of HIV self-testing and STI self-collection can increase testing rates, and access to these kits through mobile applications (apps) could help facilitate YMSM using HIV self-testing and STI self-collection.

methodsData for this study comes from two pilot randomized controlled trials (RCTs) of mobile apps within the Adolescent Trials Network-LYNX and MyChoices-aimed to increase HIV/STI testing among YMSM (age 15-24) who had not recently tested for HIV and were at high risk for HIV acquisition across five US cities. Both apps include the ability to order a HIV self-test with rapid results and a kit for STI self-collection and mailing of samples for syphilis, gonorrhea and chlamydia to a lab for testing. Using assessments of app users (n=80) at pre-randomization and at 3- and 6-months post-randomization and online interview data from a purposive sample of app users (n=37), we report on experiences and lessons learned with HIV self-testing and STI self-collection kits ordered via the apps.

resultsParticipants were on average 20.7 years of age (SD =2.4), and 49% were non-White or multiple race/ethnicity. Sixty-three percent had a prior HIV test. Over half (58%) had a prior STI test, but only 3% had tested within the past 3 months. Nearly two-thirds ordered an HIV self-testing kit; of whom, 75% reported using at least one self-test kit over the study period. STI self-collection kit ordering rates were also high (54%); however, STI self-collection kit return rates were lower (13%), but with a high positivity rate (5.3%). Both HIV self-testing and STI self-collection kits were highly acceptable, and 87% reported that it was extremely/very helpful to be able to order these kits through the apps. The most common reason for not ordering the HIV/STI kits was preferring to test at a clinic. In interviews, participants expressed feeling empowered by being able to test at home; however, they also raised concerns around STI sample collection.

conclusionsHIV self-testing and STI self-collection kit ordering via mobile apps is feasible, acceptable and may show promise in increasing testing rates among YMSM. The LYNX and MyChoices apps are currently being tested in a full-scale efficacy trial, and if successful, these innovative mobile apps could be scaled up to efficiently increase HIV/STI testing among youth across the US.

Indexed as

HIVmobile appsSelf-testingsexually transmitted infections (STIs)young men who have sex with men (YMSM)

Identifiers

PMID33898595
PMCPMC8063023

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.